Reply: BAG3 protein in advanced-stage heart failure

JACC: Heart Failure

Volumn 2, Issue 6, 2014, Pages 675-

  Storrow, Alan B ^a   Jenkins, Cathy A ^a   Self, Wesley H ^a   Alexander, Pauline T ^a   Barrett, Tyler W ^a   Han, Jin H ^a   McNaughton, Candace D ^a   Heavrin, Benjamin S ^a   Gheorghiade, Mihai ^a   Collins, Sean P ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAG3; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LETTER; OUTCOME ASSESSMENT; PATIENT MONITORING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

EID: 84964308513     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2014.05.013     Document Type: Letter

References (5)

1. Storrow A.B., Jenkins C.A., Self W.H., et al. The burden of acute heart failure on U.S. emergency departments. JAm Coll Cardiol HF 2014, 2:269-277.
2. Januzzi J.L., Felker G.M. Surfing the biomarker tsunami at JACC: Heart Failure. JAm Coll Cardiol HF 2013, 1:213-215.
3. Collins S., Storrow A. Moving toward comprehensive acute heart failure risk assessment in the emergency department. JAm Coll Cardiol HF 2013, 1:273-280.
4. Collins S.P., Pang P.S., Fonarow G.C., Yancy C.W., Bonow R.O., Gheorghiade M. Ishospital admission for heart failure really necessary? The role of the emergency department and observation unit in preventing hospitalization andrehospitalization. JAm Coll Cardiol 2013, 61:121-126.
5. Collins S.P., Storrow A.B. Acute heart failure risk stratification: can we define low risk?. Heart Fail Clin 2009, 5:75-83. vii.